• Publications
  • Influence
Therapeutic liabilities of in vivo viral vector tropism: adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivity.
The N-methyl-D-aspartic acid (NMDA) receptor provides a potential target for gene therapy of focal seizure disorders. To test this approach, we cloned a 729-bp NMDA receptor (NMDAR1) cDNA fragment inExpand
  • 61
  • 5
Novel Transcriptional Regulatory Signals in the Adeno-Associated Virus Terminal Repeat A/D Junction Element
ABSTRACT Adeno-associated virus (AAV) type 2 vectors transfer stable, long-term gene expression to diverse cell types in vivo. Many gene therapy applications require the control of long-termExpand
  • 103
  • 3
Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo
Neuropeptide Y (NPY) is a 36-amino-acid peptide that attenuates seizure activity following direct infusion or adeno-associated virus (AAV)-mediated expression in the central nervous system. However,Expand
  • 62
  • 2
Regulation of gene expression in adeno-associated virus vectors in the brain.
Regulated adeno-associated virus (AAV) vectors have broad utility in both experimental and applied gene therapy, and to date, several regulation systems have exhibited a capability to control geneExpand
  • 34
Common factors direct transcription through the proximal sequence elements (PSEs) of the embryonic sea urchin U1, U2, and U6 genes despite minimal similarity among the PSEs.
The proximal sequence element (PSE) for the sea urchin U6 small nuclear RNA gene has been defined. The most critical nucleotides for expression, located 61 to 64 nucleotides (nt) from theExpand
  • 16
Gene Therapy: Technology
Gene therapy promises to be the next revolution in medicine, in which drugs made of genetic material can be used to treat disease. Although success has been limited thus far, new technologicalExpand
Vecteurs de signal de sécrétion
L'invention concerne des vecteurs d'apport qui permettent de transferer une sequence d'acide nucleique dans une cellule in vitro, ex vivo ou in vivo. Le vecteur d'apport comprend un segment qui codeExpand